ERS INTERNATIONAL CONGRESS 2019
5-YEAR FOLLOW-UP RESULTS OF THE ORCADES STUDY
ON MILD TO SEVERE APNEA PATIENTS TREATED WITH A MANDIBULAR REPOSITIONING DEVICE (MRD).
New clinical results about Narval CC™
Jean-Claude Meurice presents the 5-year results of ORCADES, highlighting the comfort and tolerability of the custom-made Narval CC appliance. If you’re interested in MRD therapy as an alternative to CPAP*, it’s definitely worth a watch.
Download a summary of the results.
* Narval CC is indicated to treat adults with snoring or mild to moderate Obstructive Sleep Apnea (OSA). In case of severe OSA, it is indicated after positive airway pressure (CPAP) failure, non-compliance or refusal.
Pr. Jean-Claude Meurice
Replay 30:48
Watch this symposium from Sleep and Breathing congress to learn more about digital health innovations for sleep-disordered breathing therapy optimisation.
Replay 01:28
In this interview recorded at the Sleep and Breathing congress, Professor Jean-Louis Pépin talks about big data studies in sleep-disordered breathing.
Replay 01:17
Interview with Daniela Ehrsam-Tosi, Medical Affairs Manager at ResMed, on how digital technology can support the management of patients with sleep-disordered breathing.
